ITL News & Events

MyHealthTest Launches its Fourth Test Service

ITL Health Group (ASX:ITD), is pleased to announce that its wholly owned subsidiary MyHealthTest Pty Ltd (MHT), the direct to consumer pathology test provider, has launched a prostate specific antigen (PSA) test service to help men who wish to monitor their PSA level from home.  The test means MHT is now marketing four test services to total addressable markets in excess of $1bn.

Read More “MyHealthTest Launches its Fourth Test Service” »

ITL BioMedical Launches New Blood Culture Testing Product

ITL Health Group (ASX:ITD) is pleased to announce the launch of ITL BioMedical’s latest blood culture testing product, the Transfer Cap Set.

The Transfer Cap Set is a product used to transfer positive culture samples from a bacterial collection bottle to a vacuum tube safely and efficiently.  The product is designed for use in hospital laboratories that automate smearing samples from positive bacterial detection bottles.

Read More “ITL BioMedical Launches New Blood Culture Testing Product” »

ITL BioMedical Launches “ITL Clinical”, a New Brand to Target Hospital and Clinical Markets

ITL BioMedical, a division of ITL Health Group (ASX:ITD), that creates and manufacturers leading edge medical devices for the clinical, blood banking and laboratory markets, is pleased to announce the launch of a new global brand, ITL Clinical, that will feature ITL products that serve the hospital and clinical markets.

Read More “ITL BioMedical Launches “ITL Clinical”, a New Brand to Target Hospital and Clinical Markets” »

1 2 3 4